

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.89314962 |
| 2 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.82278811 |
| 3 | NADH metabolic process (GO:0006734) | 7.43422119 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.16807098 |
| 5 | lipoprotein transport (GO:0042953) | 7.14036056 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.94522395 |
| 7 | somite rostral/caudal axis specification (GO:0032525) | 6.68375200 |
| 8 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.60887334 |
| 9 | regulation of bile acid biosynthetic process (GO:0070857) | 6.48677502 |
| 10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.48139816 |
| 11 | maintenance of protein location in nucleus (GO:0051457) | 6.41021207 |
| 12 | negative regulation of epidermis development (GO:0045683) | 6.37136873 |
| 13 | intestinal absorption (GO:0050892) | 6.36170387 |
| 14 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 6.30574120 |
| 15 | fructose metabolic process (GO:0006000) | 6.07371546 |
| 16 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.95145552 |
| 17 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.66732061 |
| 18 | regulation of response to osmotic stress (GO:0047484) | 5.63242245 |
| 19 | negative regulation of telomerase activity (GO:0051974) | 5.58197843 |
| 20 | drug metabolic process (GO:0017144) | 5.55044599 |
| 21 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.54162427 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 5.47127812 |
| 23 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.42112040 |
| 24 | endocrine process (GO:0050886) | 5.42112040 |
| 25 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.42112040 |
| 26 | cytidine metabolic process (GO:0046087) | 5.31012681 |
| 27 | cytidine catabolic process (GO:0006216) | 5.31012681 |
| 28 | cytidine deamination (GO:0009972) | 5.31012681 |
| 29 | interferon-gamma production (GO:0032609) | 5.29661754 |
| 30 | negative regulation of epidermal cell differentiation (GO:0045605) | 5.27614027 |
| 31 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.14494339 |
| 32 | muscle organ morphogenesis (GO:0048644) | 5.11993893 |
| 33 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.09008515 |
| 34 | urea cycle (GO:0000050) | 5.03380634 |
| 35 | vitamin A metabolic process (GO:0006776) | 5.01480444 |
| 36 | virion attachment to host cell (GO:0019062) | 5.00609835 |
| 37 | adhesion of symbiont to host cell (GO:0044650) | 5.00609835 |
| 38 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.96773754 |
| 39 | notochord development (GO:0030903) | 4.95574252 |
| 40 | urea metabolic process (GO:0019627) | 4.95231534 |
| 41 | histone H4-K12 acetylation (GO:0043983) | 4.88670555 |
| 42 | regulation of systemic arterial blood pressure (GO:0003073) | 4.86978937 |
| 43 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.86004321 |
| 44 | rRNA methylation (GO:0031167) | 4.84667047 |
| 45 | hormone catabolic process (GO:0042447) | 4.83190245 |
| 46 | diacylglycerol metabolic process (GO:0046339) | 4.82884664 |
| 47 | cellular glucuronidation (GO:0052695) | 4.82839554 |
| 48 | phenol-containing compound catabolic process (GO:0019336) | 4.80317009 |
| 49 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.79211418 |
| 50 | glucuronate metabolic process (GO:0019585) | 4.74634093 |
| 51 | uronic acid metabolic process (GO:0006063) | 4.74634093 |
| 52 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.73624503 |
| 53 | histone H4-K5 acetylation (GO:0043981) | 4.70485480 |
| 54 | histone H4-K8 acetylation (GO:0043982) | 4.70485480 |
| 55 | rRNA transcription (GO:0009303) | 4.68040331 |
| 56 | regulation of cilium movement (GO:0003352) | 4.65174715 |
| 57 | plasma lipoprotein particle assembly (GO:0034377) | 4.62505608 |
| 58 | quinone metabolic process (GO:1901661) | 4.61395175 |
| 59 | nucleoside transmembrane transport (GO:1901642) | 4.59676164 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.58302138 |
| 61 | transepithelial transport (GO:0070633) | 4.55176456 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 4.55034189 |
| 63 | peptide catabolic process (GO:0043171) | 4.51295646 |
| 64 | peptide hormone processing (GO:0016486) | 4.50357709 |
| 65 | negative regulation of telomere maintenance (GO:0032205) | 4.48509157 |
| 66 | regulation of cellular extravasation (GO:0002691) | 4.45337989 |
| 67 | response to dietary excess (GO:0002021) | 4.36688252 |
| 68 | drug catabolic process (GO:0042737) | 4.35443064 |
| 69 | regulation of cGMP biosynthetic process (GO:0030826) | 4.34305603 |
| 70 | adhesion of symbiont to host (GO:0044406) | 4.33463816 |
| 71 | intestinal epithelial cell development (GO:0060576) | 4.33052822 |
| 72 | protein localization to kinetochore (GO:0034501) | 4.29115074 |
| 73 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.28658050 |
| 74 | rRNA modification (GO:0000154) | 4.28636302 |
| 75 | protein-lipid complex assembly (GO:0065005) | 4.21141072 |
| 76 | alkaloid metabolic process (GO:0009820) | 4.20083962 |
| 77 | renal system process involved in regulation of blood volume (GO:0001977) | 4.20023351 |
| 78 | mitochondrion distribution (GO:0048311) | 4.16563268 |
| 79 | homocysteine metabolic process (GO:0050667) | 4.06842380 |
| 80 | primitive streak formation (GO:0090009) | 4.06705176 |
| 81 | digestion (GO:0007586) | 4.04840859 |
| 82 | glycolipid catabolic process (GO:0019377) | 4.04532917 |
| 83 | cellular response to nitric oxide (GO:0071732) | 4.03167333 |
| 84 | nucleoside transport (GO:0015858) | 4.00177035 |
| 85 | phospholipid efflux (GO:0033700) | 3.99531868 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 3.99304010 |
| 87 | omega-hydroxylase P450 pathway (GO:0097267) | 3.96978270 |
| 88 | exogenous drug catabolic process (GO:0042738) | 3.95823174 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.94655906 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.94478833 |
| 91 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.92224271 |
| 92 | thyroid hormone generation (GO:0006590) | 3.90538753 |
| 93 | lipoprotein metabolic process (GO:0042157) | 3.90237001 |
| 94 | GDP-mannose metabolic process (GO:0019673) | 3.87202198 |
| 95 | drinking behavior (GO:0042756) | 3.85256577 |
| 96 | vitamin transport (GO:0051180) | 3.85211334 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83457840 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83457840 |
| 99 | vitamin transmembrane transport (GO:0035461) | 3.83091712 |
| 100 | mitotic sister chromatid segregation (GO:0000070) | 3.81350065 |
| 101 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.78478415 |
| 102 | regulation of vitamin metabolic process (GO:0030656) | 3.71722076 |
| 103 | bile acid metabolic process (GO:0008206) | 3.69382248 |
| 104 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.66214088 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.64423751 |
| 106 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.63270548 |
| 107 | regulation of cGMP metabolic process (GO:0030823) | 3.60473899 |
| 108 | cardiovascular system development (GO:0072358) | 3.60354683 |
| 109 | antibacterial humoral response (GO:0019731) | 3.55927651 |
| 110 | tachykinin receptor signaling pathway (GO:0007217) | 3.55322614 |
| 111 | thyroid hormone metabolic process (GO:0042403) | 3.55072100 |
| 112 | coenzyme catabolic process (GO:0009109) | 3.53833356 |
| 113 | vitamin biosynthetic process (GO:0009110) | 3.51903665 |
| 114 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.49899060 |
| 115 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.49801310 |
| 116 | response to nitric oxide (GO:0071731) | 3.47282014 |
| 117 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.47111011 |
| 118 | arginine metabolic process (GO:0006525) | 3.46858013 |
| 119 | antimicrobial humoral response (GO:0019730) | 3.46647558 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.42732724 |
| 121 | regulation of telomere maintenance (GO:0032204) | 3.42552787 |
| 122 | cellular response to reactive nitrogen species (GO:1902170) | 3.41668828 |
| 123 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.37977107 |
| 124 | DNA replication checkpoint (GO:0000076) | 3.35744584 |
| 125 | drug transport (GO:0015893) | 3.33911907 |
| 126 | positive regulation of odontogenesis (GO:0042482) | 3.33249364 |
| 127 | midgut development (GO:0007494) | 3.33002186 |
| 128 | bone trabecula formation (GO:0060346) | 3.32275112 |
| 129 | regulation of translation in response to stress (GO:0043555) | 3.31537587 |
| 130 | regulation of telomerase activity (GO:0051972) | 3.29480574 |
| 131 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28351416 |
| 132 | receptor recycling (GO:0001881) | 3.27711540 |
| 133 | phenylpropanoid metabolic process (GO:0009698) | 3.27587114 |
| 134 | sulfate transport (GO:0008272) | 3.24868517 |
| 135 | high-density lipoprotein particle remodeling (GO:0034375) | 3.24532096 |
| 136 | vitamin D metabolic process (GO:0042359) | 3.23480722 |
| 137 | heterochromatin organization (GO:0070828) | 3.23238898 |
| 138 | drug transmembrane transport (GO:0006855) | 3.22266724 |
| 139 | negative regulation of interleukin-2 production (GO:0032703) | 3.22044346 |
| 140 | L-ascorbic acid metabolic process (GO:0019852) | 3.21143595 |
| 141 | positive regulation of pseudopodium assembly (GO:0031274) | 3.21084990 |
| 142 | positive regulation of defense response to virus by host (GO:0002230) | 3.20878829 |
| 143 | ceramide catabolic process (GO:0046514) | 3.20741439 |
| 144 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.19570960 |
| 145 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.19217109 |
| 146 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.18586955 |
| 147 | histone H4-K16 acetylation (GO:0043984) | 3.17973388 |
| 148 | cGMP biosynthetic process (GO:0006182) | 3.16918287 |
| 149 | sulfur compound transport (GO:0072348) | 3.16520019 |
| 150 | DNA damage response, detection of DNA damage (GO:0042769) | 3.16475678 |
| 151 | plasma lipoprotein particle remodeling (GO:0034369) | 3.16139788 |
| 152 | protein-lipid complex remodeling (GO:0034368) | 3.16139788 |
| 153 | macromolecular complex remodeling (GO:0034367) | 3.16139788 |
| 154 | icosanoid secretion (GO:0032309) | 3.14428255 |
| 155 | arachidonic acid secretion (GO:0050482) | 3.14428255 |
| 156 | plasma lipoprotein particle organization (GO:0071827) | 3.14191473 |
| 157 | cholesterol homeostasis (GO:0042632) | 3.13807521 |
| 158 | urate metabolic process (GO:0046415) | 3.13616003 |
| 159 | proline metabolic process (GO:0006560) | 3.13403370 |
| 160 | maintenance of protein localization in organelle (GO:0072595) | 3.13312996 |
| 161 | glycerol metabolic process (GO:0006071) | 3.11473978 |
| 162 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.11353592 |
| 163 | cobalamin metabolic process (GO:0009235) | 3.11193756 |
| 164 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.10973049 |
| 165 | glycosylceramide metabolic process (GO:0006677) | 3.10643342 |
| 166 | phagocytosis, recognition (GO:0006910) | 3.08797427 |
| 167 | regulation of cholesterol homeostasis (GO:2000188) | 3.08332281 |
| 168 | sterol homeostasis (GO:0055092) | 3.08191956 |
| 169 | digestive system process (GO:0022600) | 3.05588900 |
| 170 | protein localization to chromosome, centromeric region (GO:0071459) | 3.04243047 |
| 171 | leukotriene metabolic process (GO:0006691) | 3.04048319 |
| 172 | ethanol oxidation (GO:0006069) | 3.03722258 |
| 173 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.02563080 |
| 174 | retinoic acid receptor signaling pathway (GO:0048384) | 3.01585674 |
| 175 | positive regulation of digestive system process (GO:0060456) | 3.01097553 |
| 176 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.97399457 |
| 177 | anterior/posterior axis specification (GO:0009948) | 2.94785897 |
| 178 | sister chromatid segregation (GO:0000819) | 2.94405204 |
| 179 | protein polyglutamylation (GO:0018095) | 2.87605552 |
| 180 | chromatin assembly (GO:0031497) | 2.85836113 |
| 181 | regulation of odontogenesis (GO:0042481) | 2.84473335 |
| 182 | epoxygenase P450 pathway (GO:0019373) | 2.83760524 |
| 183 | positive regulation of tissue remodeling (GO:0034105) | 2.83292879 |
| 184 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.83134018 |
| 185 | cyclooxygenase pathway (GO:0019371) | 2.82690018 |
| 186 | embryonic axis specification (GO:0000578) | 2.82383428 |
| 187 | regulation of G0 to G1 transition (GO:0070316) | 2.80253237 |
| 188 | cellular modified amino acid catabolic process (GO:0042219) | 2.75376609 |
| 189 | fat-soluble vitamin metabolic process (GO:0006775) | 2.73708963 |
| 190 | primary alcohol catabolic process (GO:0034310) | 2.73061851 |
| 191 | cofactor transport (GO:0051181) | 2.72730052 |
| 192 | daunorubicin metabolic process (GO:0044597) | 11.8345639 |
| 193 | polyketide metabolic process (GO:0030638) | 11.8345639 |
| 194 | doxorubicin metabolic process (GO:0044598) | 11.8345639 |
| 195 | angiotensin maturation (GO:0002003) | 11.3420987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.76523647 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 7.14934679 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 7.14934679 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 7.14934679 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.00687102 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.36965947 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 4.21989844 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.29762945 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.28691920 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25163833 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.04792877 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.94485108 |
| 13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.88725860 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.86404038 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85890074 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.80134394 |
| 17 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.79872167 |
| 18 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.79589291 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.76344890 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.69580317 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63515255 |
| 22 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.53266817 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41412002 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.41379604 |
| 25 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.36129131 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.29350509 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.26909772 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.26450154 |
| 29 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.25735549 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10526833 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.09792944 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.05140747 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05067490 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.98491269 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96326239 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92101924 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.86841626 |
| 38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.83398573 |
| 39 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.81446099 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79134807 |
| 41 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.76959447 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73078372 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71831411 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.69696867 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63308011 |
| 46 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.62017390 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58487707 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.58461723 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57534462 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57408550 |
| 51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54186581 |
| 52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.52741847 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52138674 |
| 54 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.51078265 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50400698 |
| 56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45876536 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.45156399 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44043178 |
| 59 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.42779858 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40500457 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40292753 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38312800 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35238858 |
| 64 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.35189576 |
| 65 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34686410 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34533271 |
| 67 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.31418480 |
| 68 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.30007123 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28723307 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27456871 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25128615 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23724661 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21200708 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17960248 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16244025 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14939036 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14137116 |
| 78 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13300749 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13152295 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13146242 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.12863942 |
| 82 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.10388464 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09921914 |
| 84 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09564457 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09434107 |
| 86 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.09388868 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08742029 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08178418 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07728310 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07642654 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06313470 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04556050 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03194123 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03091989 |
| 95 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.03008404 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01709971 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01701117 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01423157 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00444736 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99889173 |
| 101 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.99596848 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99168433 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98973159 |
| 104 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.98388063 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98179402 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97210542 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97128197 |
| 108 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96427518 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96337694 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95824775 |
| 111 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.95621091 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95464786 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95391270 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94658282 |
| 115 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93744370 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93553806 |
| 117 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93210956 |
| 118 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91932098 |
| 119 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91165915 |
| 120 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.90510523 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90410355 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90326504 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89645525 |
| 124 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88716029 |
| 125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88527264 |
| 126 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88216359 |
| 127 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88150534 |
| 128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86523160 |
| 129 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.86473337 |
| 130 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86352719 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85520248 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85051225 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84521430 |
| 134 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84035114 |
| 135 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83356818 |
| 136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83202501 |
| 137 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82804736 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82636908 |
| 139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82606319 |
| 140 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81931573 |
| 141 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.80146312 |
| 142 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.79843781 |
| 143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.79568207 |
| 144 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.79047956 |
| 145 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78964424 |
| 146 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78605461 |
| 147 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.78121789 |
| 148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77647778 |
| 149 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.77612283 |
| 150 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76451986 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76371079 |
| 152 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.75968070 |
| 153 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75441348 |
| 154 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75390312 |
| 155 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.75229841 |
| 156 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75091980 |
| 157 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74949907 |
| 158 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74726930 |
| 159 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.74287815 |
| 160 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74129369 |
| 161 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.73990120 |
| 162 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73212439 |
| 163 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72947155 |
| 164 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.72885707 |
| 165 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72867825 |
| 166 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72459188 |
| 167 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.71591532 |
| 168 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.65935528 |
| 169 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.65916300 |
| 170 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65883181 |
| 171 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.65775005 |
| 172 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.65440810 |
| 173 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.65406918 |
| 174 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.64563196 |
| 175 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.63276846 |
| 176 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.62359338 |
| 177 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.60466078 |
| 178 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.56750405 |
| 179 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.56453640 |
| 180 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.56440197 |
| 181 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.56367447 |
| 182 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.55713016 |
| 183 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.54115794 |
| 184 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.54073324 |
| 185 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.53883426 |
| 186 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53170832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 5.14213634 |
| 2 | MP0006292_abnormal_olfactory_placode | 5.06636041 |
| 3 | MP0002254_reproductive_system_inflammat | 4.95548442 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.93976236 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.93012836 |
| 6 | MP0003011_delayed_dark_adaptation | 4.62980590 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 4.28799520 |
| 8 | MP0005365_abnormal_bile_salt | 4.03095387 |
| 9 | MP0009840_abnormal_foam_cell | 3.70412654 |
| 10 | MP0005257_abnormal_intraocular_pressure | 3.68920766 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 3.68860188 |
| 12 | MP0005499_abnormal_olfactory_system | 3.45932166 |
| 13 | MP0005394_taste/olfaction_phenotype | 3.45932166 |
| 14 | MP0003183_abnormal_peptide_metabolism | 3.34309744 |
| 15 | MP0009379_abnormal_foot_pigmentation | 3.33157069 |
| 16 | MP0004147_increased_porphyrin_level | 3.16841652 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 3.16256595 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.96179763 |
| 19 | MP0004858_abnormal_nervous_system | 2.71212805 |
| 20 | MP0003122_maternal_imprinting | 2.55199787 |
| 21 | MP0008057_abnormal_DNA_replication | 2.50212568 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.46088510 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.45017370 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.33897113 |
| 25 | MP0003938_abnormal_ear_development | 2.33223091 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 2.20077258 |
| 27 | MP0003868_abnormal_feces_composition | 2.18507393 |
| 28 | MP0005332_abnormal_amino_acid | 2.14084858 |
| 29 | MP0002653_abnormal_ependyma_morphology | 2.12801413 |
| 30 | MP0005409_darkened_coat_color | 2.04314051 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.96552465 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.94480670 |
| 33 | MP0003121_genomic_imprinting | 1.86031368 |
| 34 | MP0006082_CNS_inflammation | 1.80248868 |
| 35 | MP0004381_abnormal_hair_follicle | 1.80080289 |
| 36 | MP0002132_abnormal_respiratory_system | 1.79240931 |
| 37 | MP0003252_abnormal_bile_duct | 1.79064363 |
| 38 | MP0001664_abnormal_digestion | 1.76266847 |
| 39 | MP0003866_abnormal_defecation | 1.69587740 |
| 40 | MP0001764_abnormal_homeostasis | 1.65964169 |
| 41 | MP0004043_abnormal_pH_regulation | 1.62110266 |
| 42 | MP0000762_abnormal_tongue_morphology | 1.61836737 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.61416762 |
| 44 | MP0005670_abnormal_white_adipose | 1.61171506 |
| 45 | MP0000490_abnormal_crypts_of | 1.60978929 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.57388319 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.54952838 |
| 48 | MP0000049_abnormal_middle_ear | 1.49830133 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.45292760 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.41096636 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.38008026 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.37065282 |
| 53 | MP0001293_anophthalmia | 1.36115324 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.34986719 |
| 55 | MP0002127_abnormal_cardiovascular_syste | 1.34217804 |
| 56 | MP0005166_decreased_susceptibility_to | 1.31737997 |
| 57 | MP0002932_abnormal_joint_morphology | 1.30925407 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.29142408 |
| 59 | MP0002098_abnormal_vibrissa_morphology | 1.28300576 |
| 60 | MP0003787_abnormal_imprinting | 1.27158717 |
| 61 | MP0002136_abnormal_kidney_physiology | 1.25226028 |
| 62 | MP0003718_maternal_effect | 1.24852160 |
| 63 | MP0000383_abnormal_hair_follicle | 1.24840905 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.24515820 |
| 65 | MP0002233_abnormal_nose_morphology | 1.22810793 |
| 66 | MP0005248_abnormal_Harderian_gland | 1.22261209 |
| 67 | MP0003879_abnormal_hair_cell | 1.22064249 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.19808182 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.16975272 |
| 70 | MP0003136_yellow_coat_color | 1.16444454 |
| 71 | MP0002396_abnormal_hematopoietic_system | 1.16052344 |
| 72 | MP0001672_abnormal_embryogenesis/_devel | 1.13037835 |
| 73 | MP0005380_embryogenesis_phenotype | 1.13037835 |
| 74 | MP0002822_catalepsy | 1.11490494 |
| 75 | MP0000609_abnormal_liver_physiology | 1.10645135 |
| 76 | MP0002092_abnormal_eye_morphology | 1.08408379 |
| 77 | MP0005377_hearing/vestibular/ear_phenot | 1.07466955 |
| 78 | MP0003878_abnormal_ear_physiology | 1.07466955 |
| 79 | MP0000566_synostosis | 1.07182803 |
| 80 | MP0000462_abnormal_digestive_system | 1.06961482 |
| 81 | MP0005360_urolithiasis | 1.05382079 |
| 82 | MP0005535_abnormal_body_temperature | 1.03231619 |
| 83 | MP0002249_abnormal_larynx_morphology | 1.01858198 |
| 84 | MP0004270_analgesia | 1.00541462 |
| 85 | MP0002971_abnormal_brown_adipose | 1.00232493 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 0.99532284 |
| 87 | MP0005448_abnormal_energy_balance | 0.99401664 |
| 88 | MP0001756_abnormal_urination | 0.99383810 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98947974 |
| 90 | MP0000432_abnormal_head_morphology | 0.98348695 |
| 91 | MP0003755_abnormal_palate_morphology | 0.98239338 |
| 92 | MP0005266_abnormal_metabolism | 0.97837432 |
| 93 | MP0003984_embryonic_growth_retardation | 0.97450131 |
| 94 | MP0002114_abnormal_axial_skeleton | 0.96648173 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.95284245 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94850850 |
| 97 | MP0003941_abnormal_skin_development | 0.94699874 |
| 98 | MP0005451_abnormal_body_composition | 0.94683303 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.94148884 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.92973584 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 0.92824800 |
| 102 | MP0001663_abnormal_digestive_system | 0.92678280 |
| 103 | MP0001849_ear_inflammation | 0.91973243 |
| 104 | MP0001873_stomach_inflammation | 0.87825994 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.84330329 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.81397378 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.81284673 |
| 108 | MP0003935_abnormal_craniofacial_develop | 0.80497363 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.80393672 |
| 110 | MP0003119_abnormal_digestive_system | 0.79992781 |
| 111 | MP0009115_abnormal_fat_cell | 0.79755096 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.79188617 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.77672096 |
| 114 | MP0005310_abnormal_salivary_gland | 0.77375675 |
| 115 | MP0008469_abnormal_protein_level | 0.76037994 |
| 116 | MP0005391_vision/eye_phenotype | 0.75936409 |
| 117 | MP0001286_abnormal_eye_development | 0.75206199 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.75124536 |
| 119 | MP0008872_abnormal_physiological_respon | 0.74453062 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.73649841 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.71185867 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.69688943 |
| 123 | MP0000428_abnormal_craniofacial_morphol | 0.68200697 |
| 124 | MP0002116_abnormal_craniofacial_bone | 0.67717578 |
| 125 | MP0002086_abnormal_extraembryonic_tissu | 0.66966026 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.65595358 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.63265891 |
| 128 | MP0000249_abnormal_blood_vessel | 0.62578505 |
| 129 | MP0003950_abnormal_plasma_membrane | 0.62027695 |
| 130 | MP0004133_heterotaxia | 0.61642187 |
| 131 | MP0003283_abnormal_digestive_organ | 0.61304324 |
| 132 | MP0003937_abnormal_limbs/digits/tail_de | 0.60436459 |
| 133 | MP0010678_abnormal_skin_adnexa | 0.60421010 |
| 134 | MP0002085_abnormal_embryonic_tissue | 0.60340478 |
| 135 | MP0010155_abnormal_intestine_physiology | 0.60125312 |
| 136 | MP0009764_decreased_sensitivity_to | 0.60029000 |
| 137 | MP0009697_abnormal_copulation | 0.59423842 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.59231079 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.58862156 |
| 140 | MP0000313_abnormal_cell_death | 0.58665697 |
| 141 | MP0000604_amyloidosis | 0.58549960 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.58473451 |
| 143 | MP0000377_abnormal_hair_follicle | 0.57993664 |
| 144 | MP0005334_abnormal_fat_pad | 0.56491845 |
| 145 | MP0004019_abnormal_vitamin_homeostasis | 0.56246855 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.56241263 |
| 147 | MP0001188_hyperpigmentation | 0.55272368 |
| 148 | MP0002970_abnormal_white_adipose | 0.54887581 |
| 149 | MP0005253_abnormal_eye_physiology | 0.53672843 |
| 150 | MP0003786_premature_aging | 0.53554455 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.53449824 |
| 152 | MP0000026_abnormal_inner_ear | 0.52272232 |
| 153 | MP0003077_abnormal_cell_cycle | 0.52223074 |
| 154 | MP0000537_abnormal_urethra_morphology | 0.52086981 |
| 155 | MP0001270_distended_abdomen | 0.52036184 |
| 156 | MP0003724_increased_susceptibility_to | 0.51989507 |
| 157 | MP0002078_abnormal_glucose_homeostasis | 0.51851494 |
| 158 | MP0005025_abnormal_response_to | 0.51428664 |
| 159 | MP0006138_congestive_heart_failure | 0.51006421 |
| 160 | MP0001485_abnormal_pinna_reflex | 0.50088421 |
| 161 | MP0005671_abnormal_response_to | 0.50059601 |
| 162 | MP0003137_abnormal_impulse_conducting | 0.49856792 |
| 163 | MP0003436_decreased_susceptibility_to | 0.49588061 |
| 164 | MP0001835_abnormal_antigen_presentation | 0.49489183 |
| 165 | MP0002796_impaired_skin_barrier | 0.49214141 |
| 166 | MP0000613_abnormal_salivary_gland | 0.48930653 |
| 167 | MP0003123_paternal_imprinting | 0.48903500 |
| 168 | MP0000465_gastrointestinal_hemorrhage | 0.48000829 |
| 169 | MP0009785_altered_susceptibility_to | 0.47512743 |
| 170 | MP0003953_abnormal_hormone_level | 0.47269332 |
| 171 | MP0005501_abnormal_skin_physiology | 0.47009965 |
| 172 | MP0003195_calcinosis | 0.46628626 |
| 173 | MP0008260_abnormal_autophagy | 0.45976595 |
| 174 | MP0002896_abnormal_bone_mineralization | 0.45648417 |
| 175 | MP0005376_homeostasis/metabolism_phenot | 0.43816596 |
| 176 | MP0005395_other_phenotype | 0.42631138 |
| 177 | MP0009333_abnormal_splenocyte_physiolog | 0.42551857 |
| 178 | MP0004947_skin_inflammation | 0.41103704 |
| 179 | MP0001881_abnormal_mammary_gland | 0.38953099 |
| 180 | MP0003303_peritoneal_inflammation | 0.38462523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.41996516 |
| 2 | Hydroxyprolinuria (HP:0003080) | 7.40260274 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 7.40260274 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.22262643 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 5.93797849 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.34636467 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.24557602 |
| 8 | Hepatoblastoma (HP:0002884) | 5.10343706 |
| 9 | Chronic diarrhea (HP:0002028) | 5.03370489 |
| 10 | Widely patent fontanelles and sutures (HP:0004492) | 4.93511827 |
| 11 | Abnormality of vitamin B metabolism (HP:0004340) | 4.89965568 |
| 12 | Confusion (HP:0001289) | 4.68447349 |
| 13 | Fat malabsorption (HP:0002630) | 4.66784025 |
| 14 | Chromsome breakage (HP:0040012) | 4.53095577 |
| 15 | Ileus (HP:0002595) | 4.52045401 |
| 16 | Rib fusion (HP:0000902) | 4.51991502 |
| 17 | Acanthocytosis (HP:0001927) | 4.47837837 |
| 18 | Hypoplasia of the fovea (HP:0007750) | 4.34104113 |
| 19 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.34104113 |
| 20 | Hyperglycinuria (HP:0003108) | 4.22628263 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 4.21009576 |
| 22 | Abnormality of vitamin metabolism (HP:0100508) | 4.06262844 |
| 23 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.98556326 |
| 24 | Glycosuria (HP:0003076) | 3.80644844 |
| 25 | Abnormality of urine glucose concentration (HP:0011016) | 3.80644844 |
| 26 | Nausea (HP:0002018) | 3.79790358 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.75241412 |
| 28 | Pigmentary retinal degeneration (HP:0001146) | 3.68579260 |
| 29 | Embryonal renal neoplasm (HP:0011794) | 3.67523341 |
| 30 | Proximal tubulopathy (HP:0000114) | 3.66109065 |
| 31 | Wide cranial sutures (HP:0010537) | 3.65323770 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.62003164 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62003164 |
| 34 | Xanthomatosis (HP:0000991) | 3.60743083 |
| 35 | Thin bony cortex (HP:0002753) | 3.57689013 |
| 36 | Multiple enchondromatosis (HP:0005701) | 3.54255742 |
| 37 | Anomalous pulmonary venous return (HP:0010772) | 3.52332755 |
| 38 | Potter facies (HP:0002009) | 3.47423670 |
| 39 | Facial shape deformation (HP:0011334) | 3.47423670 |
| 40 | Nephrolithiasis (HP:0000787) | 3.40325168 |
| 41 | Reduced antithrombin III activity (HP:0001976) | 3.38432376 |
| 42 | Partial duplication of thumb phalanx (HP:0009944) | 3.36896506 |
| 43 | Testicular atrophy (HP:0000029) | 3.35128114 |
| 44 | Abnormality of the fovea (HP:0000493) | 3.28764106 |
| 45 | Hyperuricemia (HP:0002149) | 3.23545385 |
| 46 | Increased purine levels (HP:0004368) | 3.23545385 |
| 47 | Metabolic alkalosis (HP:0200114) | 3.23190328 |
| 48 | Rectovaginal fistula (HP:0000143) | 3.15603202 |
| 49 | Rectal fistula (HP:0100590) | 3.15603202 |
| 50 | Bifid tongue (HP:0010297) | 3.13540088 |
| 51 | Alkalosis (HP:0001948) | 3.11333290 |
| 52 | Hypolipoproteinemia (HP:0010981) | 3.11062068 |
| 53 | Hypophosphatemia (HP:0002148) | 3.09918767 |
| 54 | Abnormality of the lower motor neuron (HP:0002366) | 3.07228653 |
| 55 | Megaloblastic anemia (HP:0001889) | 3.07078803 |
| 56 | Steatorrhea (HP:0002570) | 3.06609715 |
| 57 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.06534193 |
| 58 | Villous atrophy (HP:0011473) | 3.06534193 |
| 59 | Nasolacrimal duct obstruction (HP:0000579) | 3.06395541 |
| 60 | Abnormality of the pulmonary veins (HP:0011718) | 3.05327447 |
| 61 | Hyperactive renin-angiotensin system (HP:0000841) | 3.01804436 |
| 62 | Abnormal lung lobation (HP:0002101) | 3.00481479 |
| 63 | Meckel diverticulum (HP:0002245) | 2.99913670 |
| 64 | Abdominal distention (HP:0003270) | 2.98329600 |
| 65 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.94819942 |
| 66 | Intestinal fistula (HP:0100819) | 2.93669125 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.93457092 |
| 68 | Cheilitis (HP:0100825) | 2.88556780 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.86501518 |
| 70 | Periauricular skin pits (HP:0100277) | 2.85568944 |
| 71 | Preauricular pit (HP:0004467) | 2.85568944 |
| 72 | Malnutrition (HP:0004395) | 2.85159206 |
| 73 | Abnormal urine phosphate concentration (HP:0012599) | 2.84991808 |
| 74 | Partial duplication of the phalanx of hand (HP:0009999) | 2.84056554 |
| 75 | Abnormality of the ileum (HP:0001549) | 2.82830297 |
| 76 | Congenital sensorineural hearing impairment (HP:0008527) | 2.82149174 |
| 77 | Neoplasm of striated muscle (HP:0009728) | 2.81213798 |
| 78 | Hyperammonemia (HP:0001987) | 2.81062175 |
| 79 | Ependymoma (HP:0002888) | 2.80507671 |
| 80 | Rhabdomyosarcoma (HP:0002859) | 2.78532310 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.75889065 |
| 82 | Fused cervical vertebrae (HP:0002949) | 2.75320899 |
| 83 | Abnormality of the salivary glands (HP:0010286) | 2.73018424 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72376524 |
| 85 | Microvesicular hepatic steatosis (HP:0001414) | 2.71780481 |
| 86 | Hyperphosphaturia (HP:0003109) | 2.71437839 |
| 87 | Vaginal fistula (HP:0004320) | 2.70278331 |
| 88 | Posterior subcapsular cataract (HP:0007787) | 2.66193981 |
| 89 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.63316694 |
| 90 | Upper limb muscle weakness (HP:0003484) | 2.62790585 |
| 91 | Hyperventilation (HP:0002883) | 2.61957009 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59990480 |
| 93 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.58389516 |
| 94 | Enlarged epiphyses (HP:0010580) | 2.57717194 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.57482168 |
| 96 | Combined immunodeficiency (HP:0005387) | 2.56152394 |
| 97 | Hypotension (HP:0002615) | 2.55967608 |
| 98 | Horizontal nystagmus (HP:0000666) | 2.55927988 |
| 99 | Delayed epiphyseal ossification (HP:0002663) | 2.55552979 |
| 100 | Pendular nystagmus (HP:0012043) | 2.54008651 |
| 101 | Gout (HP:0001997) | 2.51913397 |
| 102 | Shawl scrotum (HP:0000049) | 2.51311932 |
| 103 | Hypochromic anemia (HP:0001931) | 2.49312585 |
| 104 | Sensory axonal neuropathy (HP:0003390) | 2.49281557 |
| 105 | Hyperparathyroidism (HP:0000843) | 2.48881126 |
| 106 | Type I transferrin isoform profile (HP:0003642) | 2.47755232 |
| 107 | Hemorrhage of the eye (HP:0011885) | 2.45969064 |
| 108 | Abnormality of the lacrimal duct (HP:0011481) | 2.45721661 |
| 109 | Focal segmental glomerulosclerosis (HP:0000097) | 2.44836976 |
| 110 | Abnormality of renin-angiotensin system (HP:0000847) | 2.40620400 |
| 111 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.39468117 |
| 112 | Dyschromatopsia (HP:0007641) | 2.38986197 |
| 113 | Epidermoid cyst (HP:0200040) | 2.38980910 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38321768 |
| 115 | Tongue fasciculations (HP:0001308) | 2.35826935 |
| 116 | Impulsivity (HP:0100710) | 2.34540104 |
| 117 | Short humerus (HP:0005792) | 2.33758342 |
| 118 | Duplication of thumb phalanx (HP:0009942) | 2.32841999 |
| 119 | Metabolic acidosis (HP:0001942) | 2.32746455 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 2.31798848 |
| 121 | Abnormality of the preputium (HP:0100587) | 2.28864580 |
| 122 | Febrile seizures (HP:0002373) | 2.28669320 |
| 123 | Complement deficiency (HP:0004431) | 2.28663228 |
| 124 | Small intestinal stenosis (HP:0012848) | 2.27783519 |
| 125 | Duodenal stenosis (HP:0100867) | 2.27783519 |
| 126 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26382559 |
| 127 | Abnormality of the costochondral junction (HP:0000919) | 2.26371905 |
| 128 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24938466 |
| 129 | Eczematoid dermatitis (HP:0000976) | 2.24581006 |
| 130 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.20755927 |
| 131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.20622431 |
| 132 | Abnormality of complement system (HP:0005339) | 2.20157818 |
| 133 | Trismus (HP:0000211) | 2.19723065 |
| 134 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.17807663 |
| 135 | Supernumerary spleens (HP:0009799) | 2.16128623 |
| 136 | Protuberant abdomen (HP:0001538) | 2.12983964 |
| 137 | Abnormal glucose tolerance (HP:0001952) | 2.12677991 |
| 138 | Glomerulonephritis (HP:0000099) | 2.11324493 |
| 139 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10726137 |
| 140 | Large earlobe (HP:0009748) | 2.08415381 |
| 141 | Skin pits (HP:0100276) | 2.08056506 |
| 142 | Renal tubular acidosis (HP:0001947) | 2.07087156 |
| 143 | Facial cleft (HP:0002006) | 2.05501383 |
| 144 | Bile duct proliferation (HP:0001408) | 2.05258738 |
| 145 | Abnormal biliary tract physiology (HP:0012439) | 2.05258738 |
| 146 | Abnormality of the nasolacrimal system (HP:0000614) | 2.05162782 |
| 147 | Irritability (HP:0000737) | 2.04724771 |
| 148 | Poikilocytosis (HP:0004447) | 2.04042233 |
| 149 | Embryonal neoplasm (HP:0002898) | 2.03859226 |
| 150 | Abnormality of chromosome segregation (HP:0002916) | 2.03295155 |
| 151 | Subcapsular cataract (HP:0000523) | 2.02178880 |
| 152 | Osteomalacia (HP:0002749) | 2.01390735 |
| 153 | Pancreatitis (HP:0001733) | 2.00778453 |
| 154 | Abnormality of the pubic bones (HP:0003172) | 2.00041817 |
| 155 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.6692446 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98455515 |
| 157 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97940275 |
| 158 | Muscle fibrillation (HP:0010546) | 1.96881770 |
| 159 | Gingivitis (HP:0000230) | 1.96438159 |
| 160 | Supernumerary nipples (HP:0002558) | 1.95562223 |
| 161 | Amyotrophic lateral sclerosis (HP:0007354) | 1.94887001 |
| 162 | Cerebral palsy (HP:0100021) | 1.92465654 |
| 163 | Hyperphosphatemia (HP:0002905) | 1.90478097 |
| 164 | Abnormality of the astrocytes (HP:0100707) | 1.90161587 |
| 165 | Astrocytoma (HP:0009592) | 1.90161587 |
| 166 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.89958953 |
| 167 | Abnormal cartilage morphology (HP:0002763) | 1.89467729 |
| 168 | Generalized hypotonia (HP:0001290) | 1.87860398 |
| 169 | Preauricular skin tag (HP:0000384) | 1.87611480 |
| 170 | Progressive external ophthalmoplegia (HP:0000590) | 1.86673911 |
| 171 | Microretrognathia (HP:0000308) | 1.86620321 |
| 172 | Increased connective tissue (HP:0009025) | 1.85556020 |
| 173 | Intrahepatic cholestasis (HP:0001406) | 1.85391704 |
| 174 | Dicarboxylic aciduria (HP:0003215) | 1.84768737 |
| 175 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84768737 |
| 176 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83454343 |
| 177 | Renal tubular dysfunction (HP:0000124) | 1.83255735 |
| 178 | Gastrointestinal dysmotility (HP:0002579) | 1.83138204 |
| 179 | Prostate neoplasm (HP:0100787) | 1.82888895 |
| 180 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82336732 |
| 181 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82336732 |
| 182 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82336732 |
| 183 | Glomerulosclerosis (HP:0000096) | 1.82208225 |
| 184 | Abnormality of the duodenum (HP:0002246) | 1.82111478 |
| 185 | Orchitis (HP:0100796) | 1.81538140 |
| 186 | Nephritis (HP:0000123) | 1.79926572 |
| 187 | Abnormality of the prostate (HP:0008775) | 1.79425715 |
| 188 | Generalized aminoaciduria (HP:0002909) | 1.79031271 |
| 189 | Multiple lipomas (HP:0001012) | 1.76743586 |
| 190 | Right ventricular cardiomyopathy (HP:0011663) | 1.75473729 |
| 191 | Elevated alkaline phosphatase (HP:0003155) | 1.72826524 |
| 192 | Rickets (HP:0002748) | 1.69101899 |
| 193 | Growth hormone excess (HP:0000845) | 1.66298810 |
| 194 | Lethargy (HP:0001254) | 1.65770873 |
| 195 | White forelock (HP:0002211) | 1.64483852 |
| 196 | Hypokalemia (HP:0002900) | 1.64372961 |
| 197 | Metaphyseal irregularity (HP:0003025) | 1.62961245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.25903171 |
| 2 | CDK12 | 7.69987536 |
| 3 | GRK5 | 4.79829628 |
| 4 | GRK6 | 4.06951083 |
| 5 | GRK1 | 3.88741331 |
| 6 | ADRBK2 | 3.75927190 |
| 7 | ERN1 | 3.75829502 |
| 8 | RIPK1 | 3.62922203 |
| 9 | GRK7 | 2.84930185 |
| 10 | CSF1R | 2.80892817 |
| 11 | AKT3 | 2.59156110 |
| 12 | MAPK7 | 2.47139450 |
| 13 | TTK | 2.46252157 |
| 14 | TGFBR2 | 2.41314791 |
| 15 | MATK | 2.40188664 |
| 16 | MST1R | 2.23293637 |
| 17 | OXSR1 | 2.10162956 |
| 18 | STK39 | 2.01722396 |
| 19 | FGFR4 | 2.00588298 |
| 20 | WNK1 | 1.98996036 |
| 21 | TESK2 | 1.92560499 |
| 22 | PRKG2 | 1.90808441 |
| 23 | TYRO3 | 1.86370455 |
| 24 | STK10 | 1.78631940 |
| 25 | EPHA2 | 1.78522582 |
| 26 | TYK2 | 1.68807406 |
| 27 | PTK6 | 1.65790735 |
| 28 | MOS | 1.49053428 |
| 29 | EPHA3 | 1.47404407 |
| 30 | EPHB2 | 1.46821796 |
| 31 | EIF2AK2 | 1.46222852 |
| 32 | DDR2 | 1.44144912 |
| 33 | PDK2 | 1.42903905 |
| 34 | MAP3K12 | 1.40048726 |
| 35 | CDK7 | 1.38656265 |
| 36 | MAP4K1 | 1.36441748 |
| 37 | CAMK4 | 1.35292253 |
| 38 | MST4 | 1.33310673 |
| 39 | EPHA4 | 1.28966313 |
| 40 | EPHB1 | 1.24482132 |
| 41 | RIPK4 | 1.20835458 |
| 42 | MAP3K1 | 1.14543109 |
| 43 | CHEK2 | 1.12465275 |
| 44 | MYLK | 1.10599309 |
| 45 | PIK3CA | 1.08788792 |
| 46 | ADRBK1 | 1.06597324 |
| 47 | MAP2K6 | 1.04007910 |
| 48 | CASK | 1.02883332 |
| 49 | MARK2 | 1.02854127 |
| 50 | NTRK1 | 0.96481060 |
| 51 | STK24 | 0.94571607 |
| 52 | PRPF4B | 0.93994101 |
| 53 | FGFR3 | 0.92914997 |
| 54 | NLK | 0.92554840 |
| 55 | PDPK1 | 0.91092122 |
| 56 | MAP3K11 | 0.91024961 |
| 57 | HIPK2 | 0.87505909 |
| 58 | CDC42BPA | 0.86102034 |
| 59 | IRAK3 | 0.85976851 |
| 60 | DYRK1B | 0.85796709 |
| 61 | TESK1 | 0.84969491 |
| 62 | MAP2K4 | 0.84863200 |
| 63 | CSK | 0.83654498 |
| 64 | PAK4 | 0.81218166 |
| 65 | MAPK11 | 0.76631948 |
| 66 | PLK1 | 0.76295038 |
| 67 | IKBKB | 0.75855151 |
| 68 | PIM1 | 0.75113655 |
| 69 | ZAK | 0.74944916 |
| 70 | TAOK1 | 0.74605427 |
| 71 | YES1 | 0.73203311 |
| 72 | MAP3K3 | 0.71193029 |
| 73 | MET | 0.70865040 |
| 74 | NME1 | 0.67746831 |
| 75 | PDK1 | 0.65321783 |
| 76 | LMTK2 | 0.64522541 |
| 77 | TBK1 | 0.61197688 |
| 78 | KSR2 | 0.61048110 |
| 79 | AKT2 | 0.60135552 |
| 80 | PRKCZ | 0.60012280 |
| 81 | PRKCA | 0.59568241 |
| 82 | PDGFRA | 0.59198953 |
| 83 | PRKCI | 0.58418577 |
| 84 | TAOK2 | 0.56059610 |
| 85 | PIK3CG | 0.55017234 |
| 86 | CDK8 | 0.54110934 |
| 87 | MAPK12 | 0.53742037 |
| 88 | MAP2K2 | 0.50667798 |
| 89 | TXK | 0.49900817 |
| 90 | PRKCD | 0.49817314 |
| 91 | IGF1R | 0.49114826 |
| 92 | FER | 0.48825685 |
| 93 | ITK | 0.48647854 |
| 94 | JAK1 | 0.48214665 |
| 95 | SRC | 0.48058155 |
| 96 | RET | 0.45819740 |
| 97 | IRAK1 | 0.45142054 |
| 98 | ABL2 | 0.43423974 |
| 99 | FYN | 0.43376596 |
| 100 | CHEK1 | 0.42924648 |
| 101 | CHUK | 0.42818566 |
| 102 | MAP3K7 | 0.42073170 |
| 103 | SRPK1 | 0.41505102 |
| 104 | JAK2 | 0.41503058 |
| 105 | CDK6 | 0.41132877 |
| 106 | BLK | 0.40244403 |
| 107 | ERBB2 | 0.39660280 |
| 108 | MAP3K14 | 0.38645474 |
| 109 | CAMK2D | 0.38246251 |
| 110 | TRIB3 | 0.37474193 |
| 111 | IRAK4 | 0.36816516 |
| 112 | PTK2 | 0.35810784 |
| 113 | BTK | 0.35651155 |
| 114 | TNK2 | 0.34133067 |
| 115 | CAMK2G | 0.33223237 |
| 116 | SYK | 0.32119028 |
| 117 | ZAP70 | 0.31724633 |
| 118 | SIK3 | 0.30341806 |
| 119 | IKBKE | 0.30055966 |
| 120 | NUAK1 | 0.28976233 |
| 121 | TEC | 0.28729893 |
| 122 | CAMK2B | 0.28372248 |
| 123 | CDK19 | 0.27567501 |
| 124 | MELK | 0.26887681 |
| 125 | DAPK2 | 0.26544979 |
| 126 | KIT | 0.25205088 |
| 127 | RPS6KA2 | 0.25161772 |
| 128 | MAP3K8 | 0.24294493 |
| 129 | INSR | 0.23818851 |
| 130 | STK38L | 0.23789102 |
| 131 | LYN | 0.23342913 |
| 132 | TNIK | 0.23068424 |
| 133 | DYRK1A | 0.22319491 |
| 134 | PRKD2 | 0.21764667 |
| 135 | LCK | 0.21337815 |
| 136 | BMX | 0.21059986 |
| 137 | AURKB | 0.20929513 |
| 138 | MKNK2 | 0.20781297 |
| 139 | PRKACA | 0.18589539 |
| 140 | ATM | 0.18585667 |
| 141 | CDK2 | 0.16868096 |
| 142 | MAPKAPK2 | 0.14708024 |
| 143 | MAPK4 | 0.14501307 |
| 144 | PRKACG | 0.14113940 |
| 145 | MAPK1 | 0.13646345 |
| 146 | GSK3B | 0.12635555 |
| 147 | MAPK14 | 0.12414710 |
| 148 | DYRK2 | 0.12144617 |
| 149 | FRK | 0.12116512 |
| 150 | BMPR2 | 0.11084554 |
| 151 | MAPK3 | 0.10600557 |
| 152 | PRKAA1 | 0.10511756 |
| 153 | AURKA | 0.10272671 |
| 154 | GSK3A | 0.10238316 |
| 155 | CSNK1E | 0.10201293 |
| 156 | CSNK1A1 | 0.09363697 |
| 157 | PRKACB | 0.09000682 |
| 158 | MAP3K10 | 0.08790564 |
| 159 | PRKAA2 | 0.08044435 |
| 160 | MAP3K2 | 0.07292913 |
| 161 | CDK1 | 0.06992716 |
| 162 | PAK1 | 0.06772707 |
| 163 | NEK6 | 0.05845988 |
| 164 | MAPK10 | 0.05845950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.05041136 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.24546796 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.03905382 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.83503565 |
| 5 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.35976779 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 3.00066318 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.59221904 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.58076149 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.57812344 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.52596967 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.42078194 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41428054 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39266165 |
| 14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.06880120 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.02934385 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.00005026 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99175447 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.97069297 |
| 19 | Mineral absorption_Homo sapiens_hsa04978 | 1.88282183 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.88169865 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.83070032 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81639384 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80855562 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57868034 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52440225 |
| 26 | Thyroid cancer_Homo sapiens_hsa05216 | 1.51211307 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44145307 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.42370058 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42338673 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40804561 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40096176 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33292634 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.32358788 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29916305 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29560262 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23991405 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18939890 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16087569 |
| 39 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14723245 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04548632 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02334356 |
| 42 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.96848183 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93591388 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93497870 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91138461 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89386992 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87355417 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 0.86957592 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84044140 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84003723 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81851877 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.80064002 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78917982 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76338975 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75655650 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75352693 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74975900 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 0.73424775 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73213654 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72966934 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70528931 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69244685 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68628009 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67960422 |
| 65 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67906285 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67290578 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65764878 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.62706361 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62044882 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61868934 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61090097 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59394036 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58735962 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57328509 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56239127 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55561555 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.55299351 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54067426 |
| 79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53535767 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53164641 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53024228 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52906686 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52350616 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51916869 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48831593 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.48502952 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47849594 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47802011 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47649519 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47543605 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.47509738 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.47451235 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.47180352 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45172478 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44697414 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44190939 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44129984 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43131371 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.41584692 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41106615 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40536821 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40277765 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40129429 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39743551 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.39001892 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38477873 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37860569 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37735567 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37083009 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35876229 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35065297 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34976756 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34017904 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33472073 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33294066 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33276732 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32364792 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32297262 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32139896 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.31588206 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31456766 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31429915 |
| 123 | RNA transport_Homo sapiens_hsa03013 | 0.31167017 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.30639184 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29485511 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.29370968 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29329773 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28789633 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28483786 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.28244314 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28130841 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27739523 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26532002 |
| 134 | Cell cycle_Homo sapiens_hsa04110 | 0.26307852 |
| 135 | Base excision repair_Homo sapiens_hsa03410 | 0.26157968 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23106697 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22808092 |
| 138 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22675603 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20359668 |
| 140 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18831261 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.17166124 |
| 142 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.16927832 |
| 143 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16922984 |
| 144 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.16502874 |
| 145 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.14044255 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12910880 |
| 147 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.12345515 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.08048653 |
| 149 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07764425 |
| 150 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.07250650 |
| 151 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.05995116 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05438134 |
| 153 | Insulin secretion_Homo sapiens_hsa04911 | 0.04736645 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03041982 |
| 155 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.02987296 |

